Annual accounts receivable:
$136.29M+$21.35M(+18.57%)Summary
- As of today (July 27, 2025), AMPH annual accounts receivable is $136.29 million, with the most recent change of +$21.35 million (+18.57%) on December 31, 2024.
- During the last 3 years, AMPH annual accounts receivable has risen by +$57.48 million (+72.95%).
- AMPH annual accounts receivable is now at all-time high.
Performance
AMPH Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$144.64M+$8.35M(+6.12%)Summary
- As of today (July 27, 2025), AMPH quarterly accounts receivable is $144.64 million, with the most recent change of +$8.35 million (+6.12%) on March 31, 2025.
- Over the past year, AMPH quarterly accounts receivable has increased by +$6.52 million (+4.72%).
- AMPH quarterly accounts receivable is now at all-time high.
Performance
AMPH Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AMPH Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.6% | +4.7% |
| 3 y3 years | +73.0% | +97.7% |
| 5 y5 years | +200.3% | +150.3% |
AMPH Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.0% | at high | +87.6% |
| 5 y | 5-year | at high | +200.3% | at high | +190.1% |
| alltime | all time | at high | +496.4% | at high | +677.7% |
AMPH Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $144.64M(+6.1%) |
| Dec 2024 | $136.29M(+18.6%) | $136.29M(-2.4%) |
| Sep 2024 | - | $139.63M(+6.3%) |
| Jun 2024 | - | $131.41M(-4.9%) |
| Mar 2024 | - | $138.11M(+20.2%) |
| Dec 2023 | $114.94M(+29.4%) | $114.94M(-3.4%) |
| Sep 2023 | - | $118.99M(+13.6%) |
| Jun 2023 | - | $104.72M(+4.1%) |
| Mar 2023 | - | $100.64M(+13.3%) |
| Dec 2022 | $88.80M(+12.7%) | $88.80M(+15.2%) |
| Sep 2022 | - | $77.10M(-4.6%) |
| Jun 2022 | - | $80.81M(+10.4%) |
| Mar 2022 | - | $73.17M(-7.2%) |
| Dec 2021 | $78.80M(+19.4%) | $78.80M(+0.9%) |
| Sep 2021 | - | $78.09M(+15.0%) |
| Jun 2021 | - | $67.89M(-12.9%) |
| Mar 2021 | - | $77.94M(+18.1%) |
| Dec 2020 | $66.00M(+45.5%) | $66.00M(+26.0%) |
| Sep 2020 | - | $52.38M(+5.1%) |
| Jun 2020 | - | $49.86M(-13.7%) |
| Mar 2020 | - | $57.78M(+27.3%) |
| Dec 2019 | $45.38M | $45.38M(+0.3%) |
| Sep 2019 | - | $45.26M(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $48.82M(-11.1%) |
| Mar 2019 | - | $54.93M(+5.3%) |
| Dec 2018 | $52.16M(+44.9%) | $52.16M(+19.1%) |
| Sep 2018 | - | $43.82M(+6.1%) |
| Jun 2018 | - | $41.28M(+29.5%) |
| Mar 2018 | - | $31.88M(-11.4%) |
| Dec 2017 | $36.00M(+34.4%) | $36.00M(+49.0%) |
| Sep 2017 | - | $24.15M(+0.1%) |
| Jun 2017 | - | $24.12M(-6.8%) |
| Mar 2017 | - | $25.89M(-3.3%) |
| Dec 2016 | $26.78M(-19.4%) | $26.78M(+0.9%) |
| Sep 2016 | - | $26.55M(+14.8%) |
| Jun 2016 | - | $23.13M(+0.2%) |
| Mar 2016 | - | $23.08M(-30.5%) |
| Dec 2015 | $33.23M(+45.4%) | $33.23M(+32.9%) |
| Sep 2015 | - | $25.00M(+26.0%) |
| Jun 2015 | - | $19.83M(-8.4%) |
| Mar 2015 | - | $21.65M(-5.2%) |
| Dec 2014 | $22.85M(-7.0%) | $22.85M(-14.1%) |
| Sep 2014 | - | $26.60M(+43.0%) |
| Jun 2014 | - | $18.60M(-2.7%) |
| Mar 2014 | - | $19.11M(-22.3%) |
| Dec 2013 | $24.59M(-32.5%) | $24.59M |
| Dec 2012 | $36.41M | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual accounts receivable?
The current annual accounts receivable of AMPH is $136.29M
What is the all time high annual accounts receivable for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual accounts receivable is $136.29M
What is Amphastar Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
Over the past year, AMPH annual accounts receivable has changed by +$21.35M (+18.57%)
What is Amphastar Pharmaceuticals, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of AMPH is $144.64M
What is the all time high quarterly accounts receivable for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly accounts receivable is $144.64M
What is Amphastar Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
Over the past year, AMPH quarterly accounts receivable has changed by +$6.52M (+4.72%)